Foresight News reports that the American publicly traded company Semler Scientific, which uses Bitcoin as its primary financial reserve asset, has announced the establishment of a wholly-owned subsidiary, CardioVanta, Inc. This subsidiary will encompass its future healthcare business activities, focusing on early detection of heart failure and arrhythmia monitoring. This move will allow Semler Scientific to develop in both the Bitcoin and medical technology sectors.